Matches in Wikidata for { <http://www.wikidata.org/entity/Q91337293> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q91337293 description "article scientifique publié en 2019" @default.
- Q91337293 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91337293 description "scientific article published on 26 December 2019" @default.
- Q91337293 description "wetenschappelijk artikel" @default.
- Q91337293 description "наукова стаття, опублікована 26 грудня 2019" @default.
- Q91337293 name "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial" @default.
- Q91337293 name "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial" @default.
- Q91337293 type Item @default.
- Q91337293 label "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial" @default.
- Q91337293 label "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial" @default.
- Q91337293 prefLabel "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial" @default.
- Q91337293 prefLabel "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial" @default.
- Q91337293 P1433 Q91337293-263EF452-346A-4CB7-BA19-160483ED7B78 @default.
- Q91337293 P1476 Q91337293-B51F839C-9170-4420-AA50-E4E1383456A5 @default.
- Q91337293 P2093 Q91337293-0BE39411-BC53-4A72-A95C-29021AC438E7 @default.
- Q91337293 P2093 Q91337293-0DE0FAF4-8411-426A-B8D6-F580DBA097BB @default.
- Q91337293 P2093 Q91337293-2C62428F-D1BB-4343-8A2F-1615E7E855F3 @default.
- Q91337293 P2093 Q91337293-497430C4-02EE-4893-B9EC-9BAC9B0CA7C3 @default.
- Q91337293 P2093 Q91337293-556EBB74-D8A7-49C8-B184-10DD3862F62E @default.
- Q91337293 P2093 Q91337293-78F1B9B7-1F07-4130-BC09-806D51B77FA1 @default.
- Q91337293 P2093 Q91337293-92304486-6C9F-4459-86FA-AC94FC7A0121 @default.
- Q91337293 P2093 Q91337293-A088D703-9171-41A0-A03B-C8DF828B9CEC @default.
- Q91337293 P2093 Q91337293-D1B36749-CCEE-4FE4-98E9-6E58D96D0A60 @default.
- Q91337293 P2093 Q91337293-E4292E6F-F08E-4D2F-A239-DB665B24363F @default.
- Q91337293 P304 Q91337293-177A4EA3-5EA0-4227-95F2-C67B5B901EB3 @default.
- Q91337293 P31 Q91337293-CD51FDD0-486C-4402-9526-66A6F6D0A86A @default.
- Q91337293 P356 Q91337293-AE22FFE0-C982-417F-BFF9-5357FF0F27CC @default.
- Q91337293 P433 Q91337293-C81D4554-173D-469B-9C30-3A19A31118EA @default.
- Q91337293 P478 Q91337293-6E0E9EBE-6A03-4BC0-9D3C-63841A6B1831 @default.
- Q91337293 P50 Q91337293-4EF70D9F-73BC-45A8-BD8E-E23809271846 @default.
- Q91337293 P50 Q91337293-CFAB18F0-5291-44E9-B500-E817267211C1 @default.
- Q91337293 P577 Q91337293-48B0D102-3939-44DA-A18B-3468E86951FB @default.
- Q91337293 P698 Q91337293-BF470FED-B5DA-4E82-A6FF-81DEBA317870 @default.
- Q91337293 P921 Q91337293-1839C12C-6BD2-4B36-8FD3-52E9F0422F27 @default.
- Q91337293 P921 Q91337293-B6B6CA7F-B3DD-461C-98FF-B0CF6FA356E6 @default.
- Q91337293 P932 Q91337293-8EFE96A2-86A5-46B3-AB7D-B402AE6DA5BF @default.
- Q91337293 P356 DOM.13922 @default.
- Q91337293 P698 31742898 @default.
- Q91337293 P1433 Q5270109 @default.
- Q91337293 P1476 "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial" @default.
- Q91337293 P2093 "Anna Maria Langkilde" @default.
- Q91337293 P2093 "Fredrik Thoren" @default.
- Q91337293 P2093 "Hiroshi Ohashi" @default.
- Q91337293 P2093 "Hitomi Fujii" @default.
- Q91337293 P2093 "Hyosung Kim" @default.
- Q91337293 P2093 "Michiko Asano" @default.
- Q91337293 P2093 "Osamu Tomonaga" @default.
- Q91337293 P2093 "Tadashi Okabe" @default.
- Q91337293 P2093 "Toshitaka Yajima" @default.
- Q91337293 P2093 "Yasuko Uchigata" @default.
- Q91337293 P304 "540-548" @default.
- Q91337293 P31 Q13442814 @default.
- Q91337293 P356 "10.1111/DOM.13922" @default.
- Q91337293 P433 "4" @default.
- Q91337293 P478 "22" @default.
- Q91337293 P50 Q50609466 @default.
- Q91337293 P50 Q61150187 @default.
- Q91337293 P577 "2019-12-26T00:00:00Z" @default.
- Q91337293 P698 "31742898" @default.
- Q91337293 P921 Q124407 @default.
- Q91337293 P921 Q42824827 @default.
- Q91337293 P932 "7078973" @default.